Syros Pharmaceuticals

Syros Pharmaceuticals

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that is focused on treating diseases by mapping gene regulatory circuits.
Founded
2013
Raised
$123M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$40,000,000
Venture capital (Series C) - 2016
Redmile Group Polaris Partners Aisling Capital +5
$53,000,000
Venture capital (Series B) - 2014
Alexandria Venture ARCH Venture Partners Aisling Capital
Team Size
10+
Employees
Xconomy

Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials

Stock markets Health Science
Xconomy

Syros Files For IPO to Push “Gene Control” Drugs Through First Trials

Science Health Funding
$40,000,000 Venture capital (Series C)
PE Hub , FinSMEs

Syros Pharma raises $40 mln